Microangiopathic hemolytic anemia

Revision as of 16:39, 29 July 2011 by Lakshmi Gopalakrishnan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Microangiopathic hemolytic anemia
ICD-10 D59.4
ICD-9 283.19
DiseasesDB 29721

WikiDoc Resources for Microangiopathic hemolytic anemia

Articles

Most recent articles on Microangiopathic hemolytic anemia

Most cited articles on Microangiopathic hemolytic anemia

Review articles on Microangiopathic hemolytic anemia

Articles on Microangiopathic hemolytic anemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Microangiopathic hemolytic anemia

Images of Microangiopathic hemolytic anemia

Photos of Microangiopathic hemolytic anemia

Podcasts & MP3s on Microangiopathic hemolytic anemia

Videos on Microangiopathic hemolytic anemia

Evidence Based Medicine

Cochrane Collaboration on Microangiopathic hemolytic anemia

Bandolier on Microangiopathic hemolytic anemia

TRIP on Microangiopathic hemolytic anemia

Clinical Trials

Ongoing Trials on Microangiopathic hemolytic anemia at Clinical Trials.gov

Trial results on Microangiopathic hemolytic anemia

Clinical Trials on Microangiopathic hemolytic anemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Microangiopathic hemolytic anemia

NICE Guidance on Microangiopathic hemolytic anemia

NHS PRODIGY Guidance

FDA on Microangiopathic hemolytic anemia

CDC on Microangiopathic hemolytic anemia

Books

Books on Microangiopathic hemolytic anemia

News

Microangiopathic hemolytic anemia in the news

Be alerted to news on Microangiopathic hemolytic anemia

News trends on Microangiopathic hemolytic anemia

Commentary

Blogs on Microangiopathic hemolytic anemia

Definitions

Definitions of Microangiopathic hemolytic anemia

Patient Resources / Community

Patient resources on Microangiopathic hemolytic anemia

Discussion groups on Microangiopathic hemolytic anemia

Patient Handouts on Microangiopathic hemolytic anemia

Directions to Hospitals Treating Microangiopathic hemolytic anemia

Risk calculators and risk factors for Microangiopathic hemolytic anemia

Healthcare Provider Resources

Symptoms of Microangiopathic hemolytic anemia

Causes & Risk Factors for Microangiopathic hemolytic anemia

Diagnostic studies for Microangiopathic hemolytic anemia

Treatment of Microangiopathic hemolytic anemia

Continuing Medical Education (CME)

CME Programs on Microangiopathic hemolytic anemia

International

Microangiopathic hemolytic anemia en Espanol

Microangiopathic hemolytic anemia en Francais

Business

Microangiopathic hemolytic anemia in the Marketplace

Patents on Microangiopathic hemolytic anemia

Experimental / Informatics

List of terms related to Microangiopathic hemolytic anemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

In medicine (hematology) microangiopathic hemolytic anemia (MAHA) is a subgroup of hemolytic anemia (anemia, loss of red blood cells through destruction) caused by factors in the small blood vessels. It is identified by the finding of anemia and schistocytes on microscopy of the blood film.

Presentation

In diseases such as hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, as well as malignant hypertension, the endothelial layer of small vessels are damaged with resulting fibrin deposition and platelet aggregation. As red blood cells travel through these damaged vessels, they are shredded. The result is red cell fragmentation and intravascular hemolysis. Under the microscope, damaged red cells have the appearance of schistocytes.

Automated analysers (the machines that perform routine full blood counts in most hospitals) are generally programmed to flag blood films that display red blood cell fragments or schistocytes.

Causes

The most important causes are:

Pathophysiology

In all causes, the mechanism of MAHA is the formation of a fibrin mesh due to increased activity of the system of coagulation. The red blood cells are physically cut by these protein networks, and the fragments are identical to the schistocytes seen on light microscopy.

Template:Hematology


Template:WikiDoc Sources